In a press release from Michigan Medicine, rheumatologists detailed strategies to improve health-care inequities for Black patients with lupus. They explained that lupus is often more prevalent among Black patients; however, these patients may face delays in diagnosis as a result of symptom dismissal—leading to more severe disease and a higher risk of mortality. These barriers to treatment—in addition to high drug costs and negative side effects—can also lead to discouragement, which can deter patients from seeking or adhering to medical care. The rheumatologists outlined novel methods to combat health-care inequities, including monitoring patients’ lupus symptoms and drug side effects; educating patients on treatment options; creating more referrals; improving the diagnosis process; building trust between patients and their physicians; and raising awareness of how symptoms may present differently in patients. “We need to meet patients where they are in terms of understanding their disease, their previous health-care experiences, and the difficulties they face in accessing proper treatment … to bring them to the best health possible,” concluded Michelle Kathlenberg, MD, PhD, Professor of Rheumatology at the University of Michigan Health.